世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032601

バイオバンキング市場レポート2022-2032

Visiongain

Biobanking Market Report 2022-2032

発刊日 2022/07/11

言語英語

体裁PDF/553ページ

ライセンス/価格553ページ

0000032601

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

種類別予測(スタンドアロン、パートナーシップ)、用途別(再生医療、ライフサイエンス研究、臨床研究)、所有権別(国/地域、大学、非営利、私立)、サンプルの種類別(血液製剤、ヒト組織、核酸、細胞株、体液、その他)、製品およびサービス別(機器、消耗品、サービス、ソフトウェア)、地域および主要国別市場分析に加えて、主要企業の分析およびCOVID-19の回復シナリオ

新しい収益源を求めて、業界とその根底にあるダイナミクスについて理解を深めたいと考えている大手企業にとって、このレポートは非常に貴重な資料です。さまざまな業種に進出したり、新たな地域で既存の事業を拡大したい企業を支援します。

バイオバンクは、臨床データに関連する生物学的材料が保管される場所です。これらのサンプルは、ある種の非営利的な方法で社会に利益をもたらし、生物医学研究を促進するために、品質基準に準拠して収集、処理、保持、および処理されます。バイオバンクとして知られる情報と生物学的サンプルの大規模なコレクションは、研究のために特別に構築されました。製薬、学術機関、家畜飼育、慈善財団などの多くの業界で、これらのリポジトリは、疫学的メカニズム、予防サービス医療プログラム、慢性疾患、および疫学の分野における人口統計学的実験に再び不可欠となっています。 腫瘍標本、臍帯血、血液、および脳脊髄液は、生物標本を見つけることができるいくつかの場所のほんの一部です。

レポート詳細

目次

1 Report Overview
1.1 Introduction to Biobanking Market
1.2 What are the Objectives of this Report?
1.3 What is the Scope of the Report?
1.4 Biobanking Market Definition
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2 Executive Summary

3 Biobanking Industry Structure
3.1 Overview
3.1.1 What is Biobank
3.1.2 Key features
3.1.3 Main Components of Biobanking
3.1.4 Types of Samples Collected in Biobanks
3.1.5 Types of Biobanks
3.1.6 History of Biobanks
3.1.7 Biobanking Operations
3.1.8 Objectives of a Biobank
3.1.9 Variability in Biobanks
3.1.10 Setting up a Biobank may be Difficult Given the Complexities of Biospecimen Handling And Maintenance
3.1.11 Biobanking in Health Care: Evolution and Future Directions

4 Global Market Dynamics
4.1 Current Trends in the Global Market
4.1.1 Investment in Information Communication Technologies to Drive Market Growth
4.1.2 Commercialisation of Biobanks’ Brings a Number of Potential Benefits
4.2 Market Driving Factors
4.2.1 Increased Focus on Precision Medicine and Genetic Testing
4.2.2 Growing Demand for Umbilical Cord Blood Banking
4.2.3 Evolution of Biobanks Rapidly Enabling Creation of Massive Collections of Biological Materials and Associated Information
4.3 Market Restraining Factors
4.3.1 Private Sponsorship Has Raised a Number of Ethical Issues
4.3.2 Issues Related to Biospecimen Sample Procurement
4.3.3 Challenges Related to Variability in Biobanks
4.4 Opportunities in the Global Market
4.4.1 Opportunities for Cardiovascular Research
4.4.2 The Pandemic Has Changed All Aspects of Biobanking Industry
4.4.3 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
4.4.4 Growing Focus on the R&D of Cell Therapies
4.5 Challenges in the Global Market
4.5.1 Long-Term Sustainability of Biobanks
4.5.2 Biobanks Facing Familiar Challenges of Improving Design with Limited Resources
4.5.3 Academic Clinical Biobank's Business Plan Should Contain Risk Management and Risk Prognosis
4.6 SWOT Analysis for Global Market

5 Global Biobanking Market Analysis
5.1 Global Market Outlook
5.1.1 List of Biobanks Globally
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Market Size Estimation and Forecast by Region
6.1 Pre-COVID-19 Market Scenario
6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Market Size Estimation and Forecast Biobank Type
7.1 Standalone
7.2 Partnership
7.3 Pre-COVID-19 Market Scenario
7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Market Size Estimation and by Application
8.1 Regenerative Medicine
8.2 Life Science Research
8.3 Clinical Research
8.3.1 Treatment Research
8.3.2 Prevention Research
8.3.3 Diagnostic Research
8.3.4 Screening Research
8.3.5 Quality of Life Research
8.3.6 Genetic studies
8.3.7 Epidemiological studies
8.4 Pre-COVID-19 Market Scenario
8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Market Size Estimation and Forecast by Ownership
9.1 National/ Regional
9.2 Universities
9.3 Private
9.4 Pre-COVID-19 Market Scenario
9.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Market Size Estimation and Forecast by Sample Type
10.1 Blood Products
10.2 Human Tissues
10.3 Nucleic Acids
10.4 Cell Lines
10.5 Pre-COVID-19 Market Scenario
10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Market Size Estimation and Forecast Product and Service
11.1 Equipment
11.2 Consumables
11.3 Services
11.4 Software
11.5 Pre-COVID-19 Market Scenario
11.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 North America Biobanking Market Analysis
12.1 North America Market Size Estimation and Forecast
12.1.1 Pre-COVID-19 Market Scenario
12.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 North America Market Size Estimation and Forecast by Country
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 North America Market Size Estimation and Forecast Type
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and by "Application
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast by Ownership
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast by Sample Type
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast Product and Service
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 U.S. Biobanking Market Analysis
12.8.1 Biobanking Research and Privacy Laws in the United States
12.8.2 BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute
12.8.3 Pre-COVID-19 Market Scenario
12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 Canada Biobanking Market Analysis
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 Europe Biobanking Market Analysis
13.1 Europe Market Outlook
13.1.1 REPROCELL Signs Agency Agreement with Ajinomoto Group for the Marketing and Sales of StemFit Basic03 GMP
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Europe Market Size Estimation and Forecast by Country
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and by Application
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast by Ownership
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast by Sample Type
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast Product and Service
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Germany Biobanking Market Analysis
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 UK Biobanking Market Analysis
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 France Biobanking Market Analysis
13.11.1 Pre-COVID-19 Market Scenario
13.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Italy Biobanking Market Analysis
13.12.1 Pre-COVID-19 Market Scenario
13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Spain Biobanking Market Analysis
13.13.1 Pre-COVID-19 Market Scenario
13.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Russia Biobanking Market Analysis
13.14.1 Pre-COVID-19 Market Scenario
13.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Denmark Biobanking Market Analysis
13.15.1 Denmark Launches World-Class Biobank
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Finland Biobanking Market Analysis
13.16.1 FINGENIOUS® - A Digital Gateway to Finnish Biobanks And Biomedical Research
13.16.2 Pre-COVID-19 Market Scenario
13.16.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.17 Rest of Europe Biobanking Market Analysis
13.17.1 Switzerland Seeking to Join Six European Infrastructure Networks
13.17.2 Pre-COVID-19 Market Scenario
13.17.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Asia-Pacific Biobanking Market Analysis
14.1 Asia-Pacific Market Outlook
14.1.1 Six Government Agencies Work Together to Run the Korean Public Biobanks
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Asia-Pacific Market Size Estimation and Forecast by Country
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and by "Application
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast by Ownership
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast by Sample Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast by Product and Service
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 China Biobanking Market Analysis
14.9.1 Rapid Expansion of Biobanking in China
14.9.2 Pre-COVID-19 Market Scenario
14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 India Biobanking Market Analysis
14.10.1 Sapien Biosciences: India’s First Commercial Biobank That Helps Develop Novel Diagnostic Tests and Cures
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Japan Biobanking Market Analysis
14.11.1 Nightingale and BioBank Japan to Realise Personalised Medicine and Preventative Health in Japan
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Singapore Biobanking Market Analysis
14.12.1 Established Biobank in Singapore
14.12.2 BioBank - National Heart Centre Singapore
14.12.3 Pre-COVID-19 Market Scenario
14.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 Australia Biobanking Market Analysis
14.13.1 Australia’s First Accredited Biobank
14.13.2 NATA’s Biobanking Accreditation Set to Expand the Emerging Australian Biobanking Industry
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of Asia-Pacific Biobanking Market Analysis
14.14.1 Taiwan Biobank: A Rich Biomedical Research Database of the Taiwanese Population
14.14.2 Pre-COVID-19 Market Scenario
14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 LAMEA Biobanking Market Analysis
15.1 LAMEA Market Outlook
15.1.1 Tumor Banking for Health Research in Brazil and Latin America
15.2 LAMEA Market Size Estimation and Forecast
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 LAMEA Market Size Estimation and Forecast by Country
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 LAMEA Market Size Estimation and Forecast Type
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and by Application
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast by Ownership
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast by Sample Type
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast Product and Service
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 Egypt Biobanking Market Analysis
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 Qatar Biobanking Market Analysis
15.10.1 Qatar Biobank Launches Online Portal to Provide Researchers with Bio-samples
15.10.2 Qatar Biobank research helps more than 190 projects
15.10.3 Pre-COVID-19 Market Scenario
15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Mexico Biobanking Market Analysis
15.11.1 Trans-Hit Bio Has Established New Collaborations With Mexican Biobanks
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.1 Brazil Biobanking Market Analysis
15.1.1 Current State of Biobanking Activities in Brazil
15.1.2 Pre-COVID-19 Market Scenario
15.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.2 Saudi Arabia Biobanking Market Analysis
15.2.1 Pre-COVID-19 Market Scenario
15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.3 Rest of LAMEA Biobanking Market Analysis
15.3.1 Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
15.3.2 Pre-COVID-19 Market Scenario
15.3.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 Company Profiles
16.1 QIAGEN
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product Benchmarking
16.2 Merck & Co., Inc
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.3 Avantor Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 STEMCELL Technologies Inc
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Product Benchmarking
16.4.4 Company Recent Developments
16.5 Stemcell Holdings, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Product Benchmarking
16.6 Azenta Life Sciences
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product Benchmarking
16.6.5 Company Recent Developments
16.7 AMS Biotechnology (Europe) Ltd.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Product Benchmarking
16.7.4 Company Recent Developments
16.8 ASKION GmbH
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Product Benchmarking
16.8.4 Company Recent Developments
16.9 Bay Biosciences LLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Product Benchmarking
16.9.4 Company Recent Developments
16.10 Cureline Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Product Benchmarking
16.10.4 Company Recent Developments
16.11 Firalis SA.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Product Benchmarking
16.11.4 Company Recent Developments
16.12 Geneticist Inc..
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Product Benchmarking
16.12.4 Company Recent Developments
16.13 Hamilton Bonaduz AG
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Product Benchmarking
16.13.4 Company Recent Developments
16.14 ProteoGenex Inc.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Product Benchmarking
16.14.4 Company Recent Developments
16.15 Thermo Fisher Scientific Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product Benchmarking
16.15.5 Company Recent Developments
16.16 US Biolab Corp. Inc.
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Product Benchmarking
16.17 BIOIVT & ELEVATING SCIENCE
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product Benchmarking
16.17.4 Company Recent Developments
16.18 Boca Biolistics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product Benchmarking
16.18.4 Company Recent Developments
16.19 CTI Biotech
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product Benchmarking
16.19.4 Company Recent Developments
16.20 Isenet Biobanking
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product Benchmarking

17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations for Market Players

List of Tables
Table 1. Global Biobanking Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2. Biobanking Market Swot Analysis
Table 3. Largest Biobanking In The World
Table 4. List of Europe Biobank
Table 5. List of North and Canada Biobanking
Table 6. List of Asian Biobanks
Table 7. Global Bio banking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 8. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 11. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 12. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 13. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 16. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 17. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 18. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 21. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 22. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 23. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 26. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 27. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 28. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 31. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 32. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 33. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 36. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 37. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 38. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 41. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 42. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 43. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 46. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 47. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 48. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 51. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 52. North America Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 53. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 56. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 57. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 58. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 61. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 62. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 63. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 66. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 67. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 68. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 71. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 72. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 73. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 76. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 77. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 78. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 81. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 82. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 83. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 86. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 87. Europe Bio banking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 88. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 91. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 92. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 93. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 96. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 97. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 98. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 100. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 101. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 102. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 103. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 105. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 106. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 107. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 108. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 110. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 111. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 112. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 113. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 115. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 116. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 117. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 118. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 120. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 121. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 125. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 126. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 130. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 131. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 135. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 136. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 140. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 141. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 145. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 146. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 150. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 151. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 155. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 156. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 160. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 161. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 165. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 166. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 167. List of Asian Biobanks
Table 168. Korean Biobank List
Table 169. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 170. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 171. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 172. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 173. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 175. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 176. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 177. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 178. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 180. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 181. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 182. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 183. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 185. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 186. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 187. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 188. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 190. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 191. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 192. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 193. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 195. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 196. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 197. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 198. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 200. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 201. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 202. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 203. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 205. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 206. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 207. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 208. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 210. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 211. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 212. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 213. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 215. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 216. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 217. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 218. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 220. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 221. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 222. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 223. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 225. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 226. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 227. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 228. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 230. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 231. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 232. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 233. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 235. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 236. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 237. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 238. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 240. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V - Shaped Recovery)
Table 241. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W - Shaped Recovery)
Table 242. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U - Shaped Recovery)
Table 243. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 244. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 245. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 246. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 247. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 248. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 249. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 250. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 251. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 252. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 253. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 254. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 255. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 256. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 257. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 258. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 259. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 260. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 261. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 262. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 263. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 264. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 265. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 266. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 267. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 268. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 269. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 270. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 271. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 272. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 273. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 274. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 275. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 276. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 277. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 278. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 279. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 280. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 281. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 282. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 283. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 284. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 285. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 286. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 287. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 288. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 289. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 290. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 291. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 292. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 293. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 294. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 295. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 296. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 297. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 298. Qiagen NV.: Company Information
Table 299. Qiagen NV: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 300. Qiagen NV.: Company Product and Service Benchmarking
Table 301. Merck & Co: Company Information
Table 302. Merck & Co: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 303. Merck & Co: Company Product and Service Benchmarking
Table 304. Avantor, Inc.: Company Information
Table 305. Avantor, Inc: Company Revenue 2017-2021 (US$Mn)
Table 306. Avantor, Inc.: Company Product and Service Benchmarking
Table 307. Avantor Inc: Company Recent Developments
Table 308. STEMCELL Technologies Inc.: Company Information
Table 309. STEMCELL Technologies Inc.: Company Product and Service Benchmarking
Table 310. STEMCELL Technologies Inc.: Company Recent Developments
Table 311. Stemcell Holdings, Inc.: Company Information
Table 312. Stemcell Holdings, Inc: Company Product and Service Benchmarking
Table 313. Azenta, Inc.: Company Information
Table 314. Azenta, Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 315. Azenta, Inc.: Company Product and Service Benchmarking
Table 316. Azenta, Inc.: Company Recent Developments
Table 317. AMS Biotechnology (Europe) Ltd.: Company Information
Table 318. AMS Biotechnology (Europe) Ltd.: Company Product and Service Benchmarking
Table 319. AMS Biotechnology (Europe) Ltd.: Company Recent Developments
Table 320. ASKION GmbH: Company Information
Table 321. ASKION GmbH: Company Product and Service Benchmarking
Table 322. ASKION GmbH: Company Recent Developments
Table 323. Bay Biosciences LLC: Company Information
Table 324. Bay Biosciences LLC: Company Product and Service Benchmarking
Table 325. Bay Biosciences LLC: Company Recent Developments
Table 326. Cureline Inc.: Company Information
Table 327. Cureline Inc.: Company Product and Service Benchmarking
Table 328. Cureline Inc.: Company Recent Developments
Table 329. Firalis SA.: Company Information
Table 330. Firalis SA.: Company Product and Service Benchmarking
Table 331. Firalis SA.: Company Recent Developments
Table 332. Geneticist Inc..: Company Information
Table 333. Geneticist Inc..: Company Product and Service Benchmarking
Table 334. Geneticist Inc..: Company Recent Developments
Table 335. Hamilton Bonaduz AG: Company Information
Table 336. Hamilton Bonaduz AG: Company Product and Service Benchmarking
Table 337. Hamilton Bonaduz AG: Company Recent Developments
Table 338. ProteoGenex Inc.: Company Information
Table 339. ProteoGenex Inc.: Company Product and Service Benchmarking
Table 340. ProteoGenex Inc.: Company Recent Developments
Table 341. Thermo Fisher Scientific Inc..: Company Information
Table 342. Thermo Fisher Scientific Inc..: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 343. Thermo Fisher Scientific Inc..: Company Product and Service Benchmarking
Table 344. Thermo Fisher Scientific Inc..: Company Recent Developments
Table 345. US Biolab Corp. Inc.: Company Information
Table 346. US Biolab Corp. Inc.: Company Product and Service Benchmarking
Table 347. BIOIVT & ELEVATING SCIENCE.: Company Information
Table 348. BIOIVT & ELEVATING SCIENCE.: Company Product and Service Benchmarking
Table 349. BIOIVT & ELEVATING SCIENCE.: Company Recent Developments
Table 350. Boca Biolistics.: Company Information
Table 351. Boca Biolistics.: Company Product and Service Benchmarking
Table 352. Boca Biolistics.: Company Recent Developments
Table 353. CTI Biotech.: Company Information
Table 354. CTI Biotech.: Company Product and Service Benchmarking
Table 355. CTI Biotech.: Company Recent Developments
Table 356. Isenet Biobanking.: Company Information
Table 357. Isenet Biobanking.: Company Product and Service Benchmarking

List of Figures
Figure 1. Global Biobanking Market Segmentation
Figure 2. Current Trends in the Global Market
Figure 3. Global Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 4. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 5. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 6. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 7. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 8. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))
Figure 9. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 10. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(W - Shaped Recovery)
Figure 11. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(U - Shaped Recovery)
Figure 12. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(L - Shaped Recovery)
Figure 13. Global Biobanking Market Forecast by Type 2022, 2027, 2032 (%)
Figure 14. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 15. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 16. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 17. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 18. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 19. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%))
Figure 20. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 21. Global Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 22. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 23. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 24. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 25. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 26. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 27. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 28. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 29. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 30. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 31. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 32. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 33. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 34. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 35. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 36. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 37. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 38. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 39. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 40. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 41. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 42. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 43. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 44. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 45. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 46. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W - Shaped Recovery)
Figure 47. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U - Shaped Recovery)
Figure 48. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L - Shaped Recovery)
Figure 49. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 50. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 51. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 52. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 53. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 54. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%))
Figure 55. North America Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 56. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 57. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 58. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 59. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 60. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 61. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 62. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 63. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 64. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%))
Figure 65. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 66. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 67. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 68. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 69. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 70. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 71. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 72. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 73. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 74. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 75. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V - Shaped Recovery)
Figure 76. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W - Shaped Recovery)
Figure 77. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U - Shaped Recovery)
Figure 78. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L - Shaped Recovery)
Figure 79. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 80. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V - Shaped Recovery)
Figure 81. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W - Shaped Recovery)
Figure 82. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U - Shaped Recovery)
Figure 83. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L - Shaped Recovery)
Figure 84. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%))
Figure 85. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 86. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 87. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 88. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 89. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))
Figure 90. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 91. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W - Shaped Recovery)
Figure 92. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U - Shaped Recovery)
Figure 93. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L - Shaped Recovery)
Figure 94. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%))
Figure 95. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V - Shaped Recovery)
Figure 96. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 97. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 98. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 99. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%))
Figure 100. Europe Biobanking Market by Application2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 101. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 102. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 103. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 104. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))
Figure 105. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 106. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 107. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 108. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 109. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))
Figure 110. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 111. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W - Shaped Recovery)
Figure 112. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U - Shaped Recovery)
Figure 113. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L - Shaped Recovery)
Figure 114. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))
Figure 115. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V - Shaped Recovery)
Figure 116. Europe Biobanking Market by Product and Service, 2022-2032(USD M

この商品のレポートナンバー

0000032601

TOP